Search hospitals > Missouri > Saint Joseph
Heartland Regional Medical Center
Claim this profileSaint Joseph, Missouri 64506
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Ovarian Cancer
336 reported clinical trials
2 medical researchers
Summary
Heartland Regional Medical Center is a medical facility located in Saint Joseph, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Ovarian Cancer and other specialties. Heartland Regional Medical Center is involved with conducting 336 clinical trials across 463 conditions. There are 2 research doctors associated with this hospital, such as Jay W Carlson and Rony Abou-Jawde, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Jay W CarlsonMercy Hospital Saint Louis6 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
219 reported clinical trials
295 drugs studied
Rony Abou-Jawde, MDMosaic Life Care6 years of reported clinical research
Studies Colorectal Cancer
Studies Solid Tumors
3 reported clinical trials
7 drugs studied
Clinical Trials running at Heartland Regional Medical Center
Lung Cancer
Breast Cancer
Bladder Cancer
Cancer
Breast cancer
Ovarian Cancer
Colorectal Cancer
Esophageal cancer
Prostate Cancer
Kidney Cancer
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Heartland Regional Medical Center?
Heartland Regional Medical Center is a medical facility located in Saint Joseph, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Ovarian Cancer and other specialties. Heartland Regional Medical Center is involved with conducting 336 clinical trials across 463 conditions. There are 2 research doctors associated with this hospital, such as Jay W Carlson and Rony Abou-Jawde, MD.
Where is Heartland Regional Medical Center located?
**Heartland Regional Medical Center**
Location: 5325 Faraon St, St Joseph, MO 64506
Easily accessible by car or public transportation, Heartland Regional Medical Center is conveniently located near the intersection of Faraon St and S 53rd St in Saint Joseph, MO.
Who should I call to ask about financial aid or insurance network?
**Heartland Regional Medical Center Financial Assistance:**
- For financial assistance, contact the Financial Assistance team at (844) 652-0603. Assistance is available for low-income individuals and families, including no-interest payment plans.
- To apply, download and complete the application in black ink and mail it with proof of income and necessary documents to: 3333 W DeYoung St, Anna, IL 62906. Processing takes 10-14 days, possibly longer if additional information is needed.
**Billing & Insurance Inquiries:**
- For questions about your bill or payment options, call the Billing & Insurance department at 833-277-8084.
**General Inquiries:**
- For other questions, contact Heartland Regional Medical Center at (618) 998-7000 or visit the Contact Us page on their website.
What insurance does Heartland Regional Medical Center accept?
Heartland Regional Medical Center accepts a wide range of insurance plans, such as Medicare Advantage, Medicare/Medicaid (MMAI), Managed Medicaid, Commercial and Employer Sponsored, and Medicaid. They provide financial assistance for low-income individuals and families, alongside no-interest payment plans. For uninsured patients, the hospital offers prepayment options or alternative payment arrangements, and assists with Medicaid applications and eligibility verification during hospitalization.
What awards or recognition has Heartland Regional Medical Center received?
Heartland Regional Medical Center, located in Saint Joseph, Missouri, is a recipient of the prestigious Malcolm Baldrige National Award for Quality in 2009, highlighting its dedication to quality and performance excellence. The hospital plays a crucial role in enhancing economic vitality and the health of the region. Its accountable care organization, Heartland Regional Medical Center ACO, has successfully reduced spending and improved health outcomes for Medicare beneficiaries.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.